
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (26): 3307-3313.DOI: 10.12114/j.issn.1007-9572.2024.0300
Special Issue: 内分泌代谢性疾病最新文章合辑; 肾脏疾病最新文章合辑
• Original Research·Research Trends of Traditional Chinese Medicine • Previous Articles Next Articles
Received:2024-07-10
Revised:2024-11-10
Published:2025-09-15
Online:2025-07-22
Contact:
CHEN Xiangmei
通讯作者:
陈香美
作者简介:作者贡献:
张睿敏负责数据采集、撰写论文、统计分析、绘制图表;董哲毅、李爽负责指导论文思路;董哲毅、李爽、王倩负责文章质量控制;陈香美对文章整体负责。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0300
| 组别 | 例数 | 年龄(岁) | 性别(男/女) | 糖尿病病史[M(P25,P75),月] | BMI[M(P25,P75),kg/m2] | 收缩压(mmHg) | 舒张压(mmHg) | 血红蛋白[M(P25,P75),g/L] | eGFR[M(P25,P75),mL·min-1·(1.73 m2)-1] | |
|---|---|---|---|---|---|---|---|---|---|---|
| CKD 1期组 | 11 | 46.7±10.1 | 8/3 | 120(102,204) | 26.0(23.8,26.6) | 133±18 | 80±13 | 127.00(101.00,156.00) | 101.28(94.41,111.90) | |
| CKD 2期组 | 19 | 53.5±10.9 | 16/3 | 180(120,246) | 24.7(22.1,26.6) | 140±27 | 84±12 | 114.50(110.50,125.75) | 73.02(65.71,78.82)d | |
| CKD 3期组 | 22 | 52.3±11.9 | 14/8 | 144(120,285) | 26.0(21.7,31.5) | 148±20 | 81±14 | 101.50(92.25,113.50)de | 47.51(39.25,54.54)de | |
| CKD 4期组 | 21 | 51.2±12.3 | 16/5 | 120(78,240) | 27.1(22.2,30.1) | 145±24 | 79±13 | 112.00(102.50,120.50)de | 21.56(18.01,25.67)def | |
| CKD 5期组 | 5 | 46.6±13.8 | 4/1 | 120(30,165) | 26.8(23.3,29.4) | 137±19 | 78±10 | 101.00(84.00,106.00)de | 10.89(8.59,13.12)defg | |
| 检验统计量值 | 0.834a | 2.431c | 2.666b | 2.710b | 0.945a | 0.491a | 24.641b | 72.432b | ||
| P值 | 0.508 | 0.681 | 0.615 | 0.607 | 0.443 | 0.742 | <0.001 | <0.001 | ||
| 组别 | 血清总蛋白(g/L) | 血清白蛋白(g/L) | 总胆固醇[M(P25,P75),mmol/L] | 三酰甘油[M(P25,P75),mmol/L] | 低密度脂蛋白胆固醇[M(P25,P75),mmol/L] | 糖化血红蛋白[M(P25,P75),%] | 血清尿酸(μmol/L) | 血清肌酐[M(P25,P75),μmol/L] | 血清尿素氮[M(P25,P75),mmol/L] | 24 h尿蛋白定量[M(P25,P75),g] |
| CKD 1期组 | 62.11±6.89 | 37.59±6.47 | 4.38(3.97,5.62) | 1.94(1.50,2.36) | 2.78(2.17,3.31) | 8.50(7.30,10.25) | 358.29±121.13 | 79.10(74.95,81.50) | 5.69(4.90,6.91) | 3.00(0.43,4.78) |
| CKD 2期组 | 60.17±8.40 | 38.03±8.76 | 4.69(3.77,5.85) | 1.48(1.04,2.10) | 2.90(2.13,4.11) | 7.20(6.50,8.23) | 403.37±100.27 | 105.90(93.38,131.23)d | 6.64(5.69,10.28)d | 3.03(1.49,5.00) |
| CKD 3期组 | 57.46±7.36 | 31.52±5.11de | 4.63(3.69,5.60) | 1.66(1.27,2.81) | 3.05(1.97,3.72) | 7.30(6.05,7.88) | 390.01±98.81 | 140.25(115.58,161.18)de | 9.71(8.89,11.46)de | 5.78(2.16,8.05)de |
| CKD 4期组 | 56.98±9.98 | 31.17±5.11de | 5.02(3.81,6.75) | 1.69(1.07,2.92) | 3.63(1.87,4.76) | 7.80(6.25,9.80) | 364.85±95.28 | 274.80(216.25,320.60)def | 15.75(10.37,17.95)def | 9.15(2.54,9.89)de |
| CKD 5期组 | 62.08±9.09 | 32.86±3.89 | 5.49(3.83,7.62) | 2.59(1.33,4.27) | 3.43(2.31,4.26) | 6.75(6.00,7.58) | 416.66±80.85 | 496.20(457.00,534.50)defg | 17.87(15.33,19.44)def | 5.72(4.23,10.31)de |
| 检验统计量值 | 1.114a | 4.110a | 1.725b | 1.448b | 1.748b | 3.357b | 0.696a | 56.245b | 44.460b | 12.746b |
| P值 | 0.357 | 0.005 | 0.786 | 0.836 | 0.782 | 0.500 | 0.597 | <0.001 | <0.001 | 0.013 |
Table 1 Comparison of the clinical data of DN patients at various CKD stages
| 组别 | 例数 | 年龄(岁) | 性别(男/女) | 糖尿病病史[M(P25,P75),月] | BMI[M(P25,P75),kg/m2] | 收缩压(mmHg) | 舒张压(mmHg) | 血红蛋白[M(P25,P75),g/L] | eGFR[M(P25,P75),mL·min-1·(1.73 m2)-1] | |
|---|---|---|---|---|---|---|---|---|---|---|
| CKD 1期组 | 11 | 46.7±10.1 | 8/3 | 120(102,204) | 26.0(23.8,26.6) | 133±18 | 80±13 | 127.00(101.00,156.00) | 101.28(94.41,111.90) | |
| CKD 2期组 | 19 | 53.5±10.9 | 16/3 | 180(120,246) | 24.7(22.1,26.6) | 140±27 | 84±12 | 114.50(110.50,125.75) | 73.02(65.71,78.82)d | |
| CKD 3期组 | 22 | 52.3±11.9 | 14/8 | 144(120,285) | 26.0(21.7,31.5) | 148±20 | 81±14 | 101.50(92.25,113.50)de | 47.51(39.25,54.54)de | |
| CKD 4期组 | 21 | 51.2±12.3 | 16/5 | 120(78,240) | 27.1(22.2,30.1) | 145±24 | 79±13 | 112.00(102.50,120.50)de | 21.56(18.01,25.67)def | |
| CKD 5期组 | 5 | 46.6±13.8 | 4/1 | 120(30,165) | 26.8(23.3,29.4) | 137±19 | 78±10 | 101.00(84.00,106.00)de | 10.89(8.59,13.12)defg | |
| 检验统计量值 | 0.834a | 2.431c | 2.666b | 2.710b | 0.945a | 0.491a | 24.641b | 72.432b | ||
| P值 | 0.508 | 0.681 | 0.615 | 0.607 | 0.443 | 0.742 | <0.001 | <0.001 | ||
| 组别 | 血清总蛋白(g/L) | 血清白蛋白(g/L) | 总胆固醇[M(P25,P75),mmol/L] | 三酰甘油[M(P25,P75),mmol/L] | 低密度脂蛋白胆固醇[M(P25,P75),mmol/L] | 糖化血红蛋白[M(P25,P75),%] | 血清尿酸(μmol/L) | 血清肌酐[M(P25,P75),μmol/L] | 血清尿素氮[M(P25,P75),mmol/L] | 24 h尿蛋白定量[M(P25,P75),g] |
| CKD 1期组 | 62.11±6.89 | 37.59±6.47 | 4.38(3.97,5.62) | 1.94(1.50,2.36) | 2.78(2.17,3.31) | 8.50(7.30,10.25) | 358.29±121.13 | 79.10(74.95,81.50) | 5.69(4.90,6.91) | 3.00(0.43,4.78) |
| CKD 2期组 | 60.17±8.40 | 38.03±8.76 | 4.69(3.77,5.85) | 1.48(1.04,2.10) | 2.90(2.13,4.11) | 7.20(6.50,8.23) | 403.37±100.27 | 105.90(93.38,131.23)d | 6.64(5.69,10.28)d | 3.03(1.49,5.00) |
| CKD 3期组 | 57.46±7.36 | 31.52±5.11de | 4.63(3.69,5.60) | 1.66(1.27,2.81) | 3.05(1.97,3.72) | 7.30(6.05,7.88) | 390.01±98.81 | 140.25(115.58,161.18)de | 9.71(8.89,11.46)de | 5.78(2.16,8.05)de |
| CKD 4期组 | 56.98±9.98 | 31.17±5.11de | 5.02(3.81,6.75) | 1.69(1.07,2.92) | 3.63(1.87,4.76) | 7.80(6.25,9.80) | 364.85±95.28 | 274.80(216.25,320.60)def | 15.75(10.37,17.95)def | 9.15(2.54,9.89)de |
| CKD 5期组 | 62.08±9.09 | 32.86±3.89 | 5.49(3.83,7.62) | 2.59(1.33,4.27) | 3.43(2.31,4.26) | 6.75(6.00,7.58) | 416.66±80.85 | 496.20(457.00,534.50)defg | 17.87(15.33,19.44)def | 5.72(4.23,10.31)de |
| 检验统计量值 | 1.114a | 4.110a | 1.725b | 1.448b | 1.748b | 3.357b | 0.696a | 56.245b | 44.460b | 12.746b |
| P值 | 0.357 | 0.005 | 0.786 | 0.836 | 0.782 | 0.500 | 0.597 | <0.001 | <0.001 | 0.013 |
| 中医证型 | 例数 | 年龄(岁) | 性别(男/女) | 糖尿病病史[M(P25,P75),月] | BMI[M(P25,P75),kg/m2] | 收缩压(mmHg) | 舒张压(mmHg) | 血红蛋白[M(P25,P75),g/L] | eGFR[M(P25,P75),mL·min-1·(1.73 m2)-1] | |
|---|---|---|---|---|---|---|---|---|---|---|
| 阴虚燥热证 | 11 | 54.6±9.9 | 10/1 | 240(138,258) | 26.0(22.8,27.2) | 142±15 | 77±7 | 119.00(109.50,154.50) | 77.38(58.79,99.82) | |
| 气阴两虚证 | 23 | 49.9±12.1 | 17/6 | 180(84,240) | 26.5(22.1,29.0) | 137±25 | 81±15 | 112.50(104.25,131.75) | 55.10(25.67,67.56)d | |
| 肝肾阴虚证 | 15 | 47.7±13.5 | 10/5 | 120(99,141) | 24.9(21.5,27.7) | 136±20 | 80±7 | 114.50(102.50,121.00) | 58.37(17.41,75.94)d | |
| 脾肾阳虚证 | 29 | 52.7±10.7 | 21/8 | 132(120,240) | 24.8(22.7,30.7) | 150±23 | 82±14 | 104.00(88.00,112.00)def | 35.84(21.56,49.46)de | |
| 检验统计量值 | 1.013a | 2.066c | 6.986b | 3.767b | 2.022a | 0.427a | 15.720b | 20.305b | ||
| P值 | 0.392 | 0.589 | 0.072 | 0.288 | 0.118 | 0.734 | 0.001 | <0.001 | ||
| 中医证型 | 血清总蛋白(g/L) | 血清白蛋白(g/L) | 总胆固醇[M(P25,P75),mmol/L] | 三酰甘油[M(P25,P75),mmol/L] | 低密度脂蛋白胆固醇[M(P25,P75),mmol/L] | 糖化血红蛋白[M(P25,P75),%] | 血清尿酸(μmol/L) | 血清肌酐[M(P25,P75),μmol/L] | 血清尿素氮[M(P25,P75),mmol/L] | 24 h尿蛋白定量[M(P25,P75),g] |
| 阴虚燥热证 | 58.40±8.65 | 37.61±9.47 | 5.21(3.62,6.50) | 2.02(1.73,2.78) | 3.24(2.04,3.88) | 7.20(6.65,9.75) | 420.66±113.32 | 89.40(81.50,118.35) | 6.25(5.55,8.25) | 5.02(1.80,7.33) |
| 气阴两虚证 | 61.80±6.52 | 36.60±5.84 | 4.68(3.92,5.13) | 1.36(1.05,2.44) | 2.67(1.82,3.35) | 7.75(6.75,8.20) | 383.81±108.02 | 140.70(108.50,242.70)d | 9.71(6.93,13.98) | 4.05(0.72,8.11) |
| 肝肾阴虚证 | 61.96±9.19 | 34.87±6.50 | 5.27(3.66,6.50) | 1.56(1.05,2.48) | 3.62(2.11,4.70) | 7.30(5.90,9.03) | 375.66±72.63 | 122.55(98.88,323.95)d | 9.15(6.56,15.05)d | 5.01(1.17,7.34) |
| 脾肾阳虚证 | 55.31±8.34ef | 30.00±6.34 def | 4.70(3.65,6.67) | 1.61(1.15,2.17) | 3.23(1.99,4.32) | 7.20(6.30,8.00) | 373.82±101.92 | 183.40(139.70,277.50)de | 11.70(8.88,15.75)de | 4.70(3.52,9.03) |
| 检验统计量值 | 3.639a | 5.679a | 0.505b | 3.257b | 1.571b | 0.470b | 0.619a | 17.623b | 19.601b | 6.060b |
| P值 | 0.017 | 0.001 | 0.918 | 0.354 | 0.666 | 0.925 | 0.605 | 0.001 | <0.001 | 0.109 |
Table 2 Comparison of the clinical data of DN patients with various TCM syndrome types
| 中医证型 | 例数 | 年龄(岁) | 性别(男/女) | 糖尿病病史[M(P25,P75),月] | BMI[M(P25,P75),kg/m2] | 收缩压(mmHg) | 舒张压(mmHg) | 血红蛋白[M(P25,P75),g/L] | eGFR[M(P25,P75),mL·min-1·(1.73 m2)-1] | |
|---|---|---|---|---|---|---|---|---|---|---|
| 阴虚燥热证 | 11 | 54.6±9.9 | 10/1 | 240(138,258) | 26.0(22.8,27.2) | 142±15 | 77±7 | 119.00(109.50,154.50) | 77.38(58.79,99.82) | |
| 气阴两虚证 | 23 | 49.9±12.1 | 17/6 | 180(84,240) | 26.5(22.1,29.0) | 137±25 | 81±15 | 112.50(104.25,131.75) | 55.10(25.67,67.56)d | |
| 肝肾阴虚证 | 15 | 47.7±13.5 | 10/5 | 120(99,141) | 24.9(21.5,27.7) | 136±20 | 80±7 | 114.50(102.50,121.00) | 58.37(17.41,75.94)d | |
| 脾肾阳虚证 | 29 | 52.7±10.7 | 21/8 | 132(120,240) | 24.8(22.7,30.7) | 150±23 | 82±14 | 104.00(88.00,112.00)def | 35.84(21.56,49.46)de | |
| 检验统计量值 | 1.013a | 2.066c | 6.986b | 3.767b | 2.022a | 0.427a | 15.720b | 20.305b | ||
| P值 | 0.392 | 0.589 | 0.072 | 0.288 | 0.118 | 0.734 | 0.001 | <0.001 | ||
| 中医证型 | 血清总蛋白(g/L) | 血清白蛋白(g/L) | 总胆固醇[M(P25,P75),mmol/L] | 三酰甘油[M(P25,P75),mmol/L] | 低密度脂蛋白胆固醇[M(P25,P75),mmol/L] | 糖化血红蛋白[M(P25,P75),%] | 血清尿酸(μmol/L) | 血清肌酐[M(P25,P75),μmol/L] | 血清尿素氮[M(P25,P75),mmol/L] | 24 h尿蛋白定量[M(P25,P75),g] |
| 阴虚燥热证 | 58.40±8.65 | 37.61±9.47 | 5.21(3.62,6.50) | 2.02(1.73,2.78) | 3.24(2.04,3.88) | 7.20(6.65,9.75) | 420.66±113.32 | 89.40(81.50,118.35) | 6.25(5.55,8.25) | 5.02(1.80,7.33) |
| 气阴两虚证 | 61.80±6.52 | 36.60±5.84 | 4.68(3.92,5.13) | 1.36(1.05,2.44) | 2.67(1.82,3.35) | 7.75(6.75,8.20) | 383.81±108.02 | 140.70(108.50,242.70)d | 9.71(6.93,13.98) | 4.05(0.72,8.11) |
| 肝肾阴虚证 | 61.96±9.19 | 34.87±6.50 | 5.27(3.66,6.50) | 1.56(1.05,2.48) | 3.62(2.11,4.70) | 7.30(5.90,9.03) | 375.66±72.63 | 122.55(98.88,323.95)d | 9.15(6.56,15.05)d | 5.01(1.17,7.34) |
| 脾肾阳虚证 | 55.31±8.34ef | 30.00±6.34 def | 4.70(3.65,6.67) | 1.61(1.15,2.17) | 3.23(1.99,4.32) | 7.20(6.30,8.00) | 373.82±101.92 | 183.40(139.70,277.50)de | 11.70(8.88,15.75)de | 4.70(3.52,9.03) |
| 检验统计量值 | 3.639a | 5.679a | 0.505b | 3.257b | 1.571b | 0.470b | 0.619a | 17.623b | 19.601b | 6.060b |
| P值 | 0.017 | 0.001 | 0.918 | 0.354 | 0.666 | 0.925 | 0.605 | 0.001 | <0.001 | 0.109 |
| 组别 | 例数 | 阴虚燥热证 | 气阴两虚证 | 肝肾阴虚证 | 脾肾阳虚证 |
|---|---|---|---|---|---|
| CKD 1期组 | 11 | 5(45.5) | 3(27.3) | 1(9.1) | 2(18.2) |
| CKD 2期组 | 19 | 4(21.1) | 8(42.1) | 6(31.6) | 1(5.3) |
| CKD 3期组 | 22 | 2(9.1) | 7(31.8) | 1(4.5) | 12(54.5) |
| CKD 4期组 | 21 | 0 | 4(19.0) | 6(28.6) | 11(52.4) |
| CKD 5期组 | 5 | 0 | 1(20.0) | 1(20.0) | 3(60.0) |
| H值 | 18.686 | ||||
| P值 | 0.001 | ||||
Table 3 Distribution of TCM syndrome types in DN patients with various CKD staging
| 组别 | 例数 | 阴虚燥热证 | 气阴两虚证 | 肝肾阴虚证 | 脾肾阳虚证 |
|---|---|---|---|---|---|
| CKD 1期组 | 11 | 5(45.5) | 3(27.3) | 1(9.1) | 2(18.2) |
| CKD 2期组 | 19 | 4(21.1) | 8(42.1) | 6(31.6) | 1(5.3) |
| CKD 3期组 | 22 | 2(9.1) | 7(31.8) | 1(4.5) | 12(54.5) |
| CKD 4期组 | 21 | 0 | 4(19.0) | 6(28.6) | 11(52.4) |
| CKD 5期组 | 5 | 0 | 1(20.0) | 1(20.0) | 3(60.0) |
| H值 | 18.686 | ||||
| P值 | 0.001 | ||||
| 变量 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 气虚证 | 0.710 | 0.518 | 1.884 | 0.170 | 2.035 | 0.738~5.613 |
| 血虚证 | 0.016 | 0.496 | 0.001 | 0.975 | 1.016 | 0.385~2.683 |
| 阴虚证 | -0.453 | 0.467 | 0.943 | 0.332 | 0.636 | 0.255~1.587 |
| 阳虚证 | 1.444 | 0.507 | 8.117 | 0.004 | 4.237 | 1.569~11.440 |
| 热证 | -0.107 | 0.463 | 0.054 | 0.817 | 0.898 | 0.363~2.226 |
| 气滞证 | 0.265 | 0.488 | 0.296 | 0.587 | 1.303 | 0.501~3.389 |
| 水停证 | 1.961 | 1.082 | 3.284 | 0.070 | 7.105 | 0.852~59.237 |
| 湿阻证 | 0.699 | 0.482 | 2.101 | 0.147 | 2.012 | 0.782~5.181 |
| 血瘀证 | 0.208 | 0.567 | 0.135 | 0.714 | 1.231 | 0.405~3.745 |
| 痰浊证 | 0.842 | 0.505 | 2.788 | 0.095 | 2.322 | 0.864~6.242 |
| 病位心 | 1.390 | 0.530 | 6.878 | 0.009 | 4.015 | 1.421~11.344 |
| 病位肝 | 0.480 | 0.680 | 0.498 | 0.481 | 1.615 | 0.426~6.124 |
| 病位脾 | 0.664 | 0.526 | 1.594 | 0.207 | 1.943 | 0.693~5.447 |
| 病位肺 | -0.260 | 0.493 | 0.278 | 0.598 | 0.771 | 0.294~2.026 |
| 病位肾 | -0.752 | 0.852 | 0.780 | 0.377 | 0.471 | 0.089~2.502 |
Table 4 Univariate Logistic regression analysis of TCM syndrome elements associated with DN accompanied by massive proteinuria
| 变量 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 气虚证 | 0.710 | 0.518 | 1.884 | 0.170 | 2.035 | 0.738~5.613 |
| 血虚证 | 0.016 | 0.496 | 0.001 | 0.975 | 1.016 | 0.385~2.683 |
| 阴虚证 | -0.453 | 0.467 | 0.943 | 0.332 | 0.636 | 0.255~1.587 |
| 阳虚证 | 1.444 | 0.507 | 8.117 | 0.004 | 4.237 | 1.569~11.440 |
| 热证 | -0.107 | 0.463 | 0.054 | 0.817 | 0.898 | 0.363~2.226 |
| 气滞证 | 0.265 | 0.488 | 0.296 | 0.587 | 1.303 | 0.501~3.389 |
| 水停证 | 1.961 | 1.082 | 3.284 | 0.070 | 7.105 | 0.852~59.237 |
| 湿阻证 | 0.699 | 0.482 | 2.101 | 0.147 | 2.012 | 0.782~5.181 |
| 血瘀证 | 0.208 | 0.567 | 0.135 | 0.714 | 1.231 | 0.405~3.745 |
| 痰浊证 | 0.842 | 0.505 | 2.788 | 0.095 | 2.322 | 0.864~6.242 |
| 病位心 | 1.390 | 0.530 | 6.878 | 0.009 | 4.015 | 1.421~11.344 |
| 病位肝 | 0.480 | 0.680 | 0.498 | 0.481 | 1.615 | 0.426~6.124 |
| 病位脾 | 0.664 | 0.526 | 1.594 | 0.207 | 1.943 | 0.693~5.447 |
| 病位肺 | -0.260 | 0.493 | 0.278 | 0.598 | 0.771 | 0.294~2.026 |
| 病位肾 | -0.752 | 0.852 | 0.780 | 0.377 | 0.471 | 0.089~2.502 |
| 变量 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 阳虚证 | 1.266 | 0.524 | 5.840 | 0.016 | 3.545 | 1.270~9.895 |
| 病位心 | 1.166 | 0.554 | 4.422 | 0.035 | 3.208 | 1.082~9.511 |
| 常量 | -0.935 | 0.489 | 3.656 | 0.056 | 0.392 |
Table 5 Multivariate Logistic regression analysis of TCM syndrome elements associated with DN accompanied by massive proteinuria
| 变量 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 阳虚证 | 1.266 | 0.524 | 5.840 | 0.016 | 3.545 | 1.270~9.895 |
| 病位心 | 1.166 | 0.554 | 4.422 | 0.035 | 3.208 | 1.082~9.511 |
| 常量 | -0.935 | 0.489 | 3.656 | 0.056 | 0.392 |
| 变量 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 气虚证 | 0.788 | 0.519 | 2.304 | 0.129 | 2.200 | 0.795~6.090 |
| 血虚证 | 0.095 | 0.497 | 0.037 | 0.848 | 1.100 | 0.415~2.913 |
| 阴虚证 | -0.798 | 0.478 | 2.790 | 0.095 | 0.450 | 0.177~1.148 |
| 阳虚证 | 1.099 | 0.493 | 4.959 | 0.026 | 3.000 | 1.141~7.890 |
| 热证 | 0.217 | 0.466 | 0.216 | 0.642 | 1.242 | 0.498~3.098 |
| 气滞证 | 0.182 | 0.489 | 0.139 | 0.709 | 1.200 | 0.460~3.128 |
| 水停证 | 1.030 | 0.828 | 1.546 | 0.214 | 2.800 | 0.552~14.191 |
| 湿阻证 | 0.154 | 0.473 | 0.106 | 0.744 | 1.167 | 0.462~2.947 |
| 血瘀证 | -0.396 | 0.598 | 0.439 | 0.508 | 0.673 | 0.208~2.173 |
| 痰浊证 | 0.760 | 0.505 | 2.266 | 0.132 | 2.139 | 0.795~5.756 |
| 病位心 | 0.666 | 0.511 | 1.699 | 0.192 | 1.947 | 0.715~5.305 |
| 病位肝 | 0.542 | 0.681 | 0.635 | 0.426 | 1.720 | 0.453~6.530 |
| 病位脾 | 0.875 | 0.545 | 2.579 | 0.108 | 2.400 | 0.824~6.987 |
| 病位肺 | 0.154 | 0.502 | 0.094 | 0.759 | 1.167 | 0.436~3.124 |
| 病位肾 | -0.045 | 0.770 | 0.003 | 0.953 | 0.956 | 0.211~4.326 |
Table 6 Univariate Logistic regression analysis of TCM syndrome elements associated with DN accompanied by eGFR < 60 mL·min-1·(1.73 m2)-1
| 变量 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 气虚证 | 0.788 | 0.519 | 2.304 | 0.129 | 2.200 | 0.795~6.090 |
| 血虚证 | 0.095 | 0.497 | 0.037 | 0.848 | 1.100 | 0.415~2.913 |
| 阴虚证 | -0.798 | 0.478 | 2.790 | 0.095 | 0.450 | 0.177~1.148 |
| 阳虚证 | 1.099 | 0.493 | 4.959 | 0.026 | 3.000 | 1.141~7.890 |
| 热证 | 0.217 | 0.466 | 0.216 | 0.642 | 1.242 | 0.498~3.098 |
| 气滞证 | 0.182 | 0.489 | 0.139 | 0.709 | 1.200 | 0.460~3.128 |
| 水停证 | 1.030 | 0.828 | 1.546 | 0.214 | 2.800 | 0.552~14.191 |
| 湿阻证 | 0.154 | 0.473 | 0.106 | 0.744 | 1.167 | 0.462~2.947 |
| 血瘀证 | -0.396 | 0.598 | 0.439 | 0.508 | 0.673 | 0.208~2.173 |
| 痰浊证 | 0.760 | 0.505 | 2.266 | 0.132 | 2.139 | 0.795~5.756 |
| 病位心 | 0.666 | 0.511 | 1.699 | 0.192 | 1.947 | 0.715~5.305 |
| 病位肝 | 0.542 | 0.681 | 0.635 | 0.426 | 1.720 | 0.453~6.530 |
| 病位脾 | 0.875 | 0.545 | 2.579 | 0.108 | 2.400 | 0.824~6.987 |
| 病位肺 | 0.154 | 0.502 | 0.094 | 0.759 | 1.167 | 0.436~3.124 |
| 病位肾 | -0.045 | 0.770 | 0.003 | 0.953 | 0.956 | 0.211~4.326 |
| 变量 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 阳虚证 | 1.099 | 0.493 | 4.959 | 0.026 | 3.000 | 1.141~7.890 |
| 常量 | <0.001 | 0.309 | <0.001 | >0.999 | >0.999 |
Table 7 Multivariate Logistic regression analysis of TCM syndrome elements associated with DN accompanied by eGFR<60 mL·min-1·(1.73 m2)-1
| 变量 | B | SE | Wald χ2值 | P值 | OR值 | 95%CI |
|---|---|---|---|---|---|---|
| 阳虚证 | 1.099 | 0.493 | 4.959 | 0.026 | 3.000 | 1.141~7.890 |
| 常量 | <0.001 | 0.309 | <0.001 | >0.999 | >0.999 |
| [1] |
|
| [2] |
Kidney Disease:Improving Global Outcomes Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease[J]. Kidney Int,2022,102(5S):S1-127. DOI:10.1016/j.kint.2022.06.008.
|
| [3] |
|
| [4] |
中国中西医结合学会,中华中医药学会,中华医学会. 糖尿病肾脏疾病中西医结合诊疗指南[EB/OL].(2023-05-31)[2024-02-15].
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
吕仁和,张洁荣,高彦彬. 消渴病(糖尿病)中医分期辨证与疗效评定标准[J]. 中国医药学报,1993,8(3):54-56.
|
| [10] |
仝小林,刘喜明,魏军平,等. 糖尿病中医防治指南[J]. 中国中医药现代远程教育,2011,9(4):148-151.
|
| [11] |
中华中医药学会. 糖尿病肾病中医防治指南[J]. 中国中医药现代远程教育,2011,9(4):151-153.
|
| [12] | |
| [13] |
|
| [14] |
胡茂芳,朱轶. 中药治疗糖尿病肾病的研究进展[J]. 中医临床研究,2024,16(11):32-37.
|
| [15] |
张玉花,李生海,王财年,等. 糖尿病肾病患者不同中医证型与肾功能及实验室指标的关系[J]. 分子诊断与治疗杂志,2022,14(8):1428-1432.
|
| [16] |
陈文英,史晓伟,张定华,等. 基于舌象及6种常见脉象特征的Ⅲ、Ⅳ期糖尿病肾病中医病机及辨证分型[J]. 中医研究,2023,36(12):20-24.
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
| [1] | SU Die, ZHANG Yan, CHEN Xiaosong, HAN Yuxia, YAN Yongbin, DUAN Junya, CHEN Xinying, ZHAO Chenghao. Outcome Measures in Randomized Controlled Trials of Traditional Chinese Medicine for Refractory Mycoplasma Pneumoniae Pneumonia in Children [J]. Chinese General Practice, 2026, 29(31): 4609-4618. |
| [2] | WANG Shuaihang, CAO Yedi, CHEN Fei, ZHU Sainan, GAO Ying. The Association between the Weight-adjusted Waist Index and Thyroid Function and Autoimmunity: Insights from NHANES Data [J]. Chinese General Practice, 2026, 29(30): 4406-4414. |
| [3] | LI Hangzhi, WANG Jiepeng, ZHANG Xiaoyi, FANG Chaoyi. Epidemiology and Comorbidities of Insomnia: Research Advances from an Integrated Chinese and Western Medical Perspective [J]. Chinese General Practice, 2026, 29(30): 4463-4471. |
| [4] | WANG Sixue, YUAN Yue, XIONG Lisha, ZHOU Chunyi, YUAN Xiangqing, FANG Xuelian, ZHANG Ailin, WANG Yuncui. Development of the Traditional Chinese Medicine Health Behaviors Stage-specific Influencing Factors Scale and Its Reliability and Validity Testing [J]. Chinese General Practice, 2026, 29(29): 4337-4344. |
| [5] | JIANG Yanlin, WANG Zhe, ZHAI Rui, ZHANG Mengjie, CHEN Xi, WANG Junhong. Screening Optimal Traditional Chinese Medicine Compound Formulas for ADHD Treatment: a Study Integrating Network Meta-analysis and Entropy-weighted TOPSIS Method [J]. Chinese General Practice, 2026, 29(27): 3985-3994. |
| [6] | YANG Zhaoheng, DANG Yuan, SHI Muran, LI Wenxin, ZHAO Yimo, WANG Zihan, WU Ning. Development of Primary Care Traditional Chinese Medicine Workforce in China: a Policy Analysis Using the Three-dimensional "Theme-instrument-evaluation" Framework [J]. Chinese General Practice, 2026, 29(27): 3906-3914. |
| [7] | YUAN Yue, WANG Sixue, YUAN Xiangqing, ZHOU Chunyi, XIONG Lisha, ZHANG Ailin, FANG Xuelian, WANG Yuncui. Development Reliability Validity Test of Traditional Chinese Medicine Health Behaviors Scale [J]. Chinese General Practice, 2026, 29(26): 3865-3872. |
| [8] | WU Ermei, SUN Dajuan, DENG Hualiang. A Review of Role of miRNA in Ulcerative Colitis and Traditional Chinese Medicine Intervention [J]. Chinese General Practice, 2026, 29(23): 3371-3378. |
| [9] | FENG Yuxi, WANG Jinjin, CAI Yi, ZHU Runzhi, ZHU Qin. Research Progress on Protein Lactylation in Kidney Diseases [J]. Chinese General Practice, 2026, 29(21): 3056-3063. |
| [10] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [11] | FENG Zhenzhen, LIU Wenrui, LI Jiansheng, GUAN Xutao, QUAN Jianfeng, GAO Hong, TIAN Jianhui, RONG Zhen, HOU Wei, ZHOU Xun. Research on the Differences in the Clinical Characteristics and Basic Pattern Distribution of 2 340 Lung Cancer Patients in Different Regions of China [J]. Chinese General Practice, 2026, 29(20): 2860-2866. |
| [12] | ZHANG Ke, ZENG Xianchang, ZOLZAYA Enkhzaya, ZHU Yelin, HUANG Yiwen, LIU Zhenxiu, TAO Feng. Effect of Xiere Xingpi Yin on Eating Behaviors and Weight-related Outcomes in Patients with Obesity: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(20): 2759-2765. |
| [13] | LIU Ying, LIU Shiwei, ZHANG Chi, SHEN Ji, ZHANG Yushan, ZHANG Jie, SANG Yingchen, WANG Youjiao, WANG Lei, ZHOU Houguang, SHI Hong. Prevalence and Associated Factors of Subjective Cognitive Decline among Older Stroke Patients in China [J]. Chinese General Practice, 2026, 29(20): 2829-2835. |
| [14] | WANG Cheng, SHI Xuefeng, YANG Yong, BAI Qian. Study on Traditional Chinese Medicine Service Capacity and Delivery Efficiency of Village Clinic in a District of Beijing [J]. Chinese General Practice, 2026, 29(19): 2631-2637. |
| [15] | MENG Zixi, ZHAO Huiduo, LIU Ruidong, WANG Beibei, JIANG Mingqiang, CHENG Xufeng. Guidelines for Diagnosis and Treatment of Acute Mastitis with Integrated Traditional Chinese and Western Medicine [J]. Chinese General Practice, 2026, 29(17): 2273-2281. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||